TNYA
Tenaya Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.41 / 10
Outperform
Analyst sentiment is overwhelmingly bullish: one analyst rates Strong Buy, yielding a weighted rating of 7.17. Fund flow is positive (overall inflow ratio 0.50) with block, medium and large investors net buying, while small and extra‑large are net sellers. Price is down 22.4%.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-12
InstitutionChardan Capital
Times predicted5
Historical Win Rate40.0%
Is money flowing into or out of TNYA?
- TNYA holds a Bullish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 7.41/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
